Обертинська, О.Г.; Obertynska, O.
(European Society of Cardiology, 2021)
Mineralocorticoid receptor antagonists (MRAs) remain underused in cases of heart failure with a reduced left ventricular ejection fraction (HFrEF) and chronic kidney disease (CKD), largely due to the fear of inducing ...